nodes	percent_of_prediction	percent_of_DWPC	metapath
Mycophenolate mofetil—UGT2B7—urinary bladder cancer	0.399	1	CbGaD
Mycophenolate mofetil—UGT2B7—Epirubicin—urinary bladder cancer	0.034	0.107	CbGbCtD
Mycophenolate mofetil—UGT1A1—Etoposide—urinary bladder cancer	0.0229	0.0721	CbGbCtD
Mycophenolate mofetil—ABCB1—Mitomycin—urinary bladder cancer	0.0221	0.0696	CbGbCtD
Mycophenolate mofetil—SLCO1B3—Methotrexate—urinary bladder cancer	0.018	0.0567	CbGbCtD
Mycophenolate mofetil—ABCC2—Carboplatin—urinary bladder cancer	0.0166	0.0523	CbGbCtD
Mycophenolate mofetil—ABCG2—Fluorouracil—urinary bladder cancer	0.0151	0.0475	CbGbCtD
Mycophenolate mofetil—ABCG2—Carboplatin—urinary bladder cancer	0.015	0.0473	CbGbCtD
Mycophenolate mofetil—ABCC2—Cisplatin—urinary bladder cancer	0.0142	0.0447	CbGbCtD
Mycophenolate mofetil—ABCC2—Etoposide—urinary bladder cancer	0.0139	0.0439	CbGbCtD
Mycophenolate mofetil—ABCG2—Cisplatin—urinary bladder cancer	0.0128	0.0404	CbGbCtD
Mycophenolate mofetil—ABCG2—Etoposide—urinary bladder cancer	0.0126	0.0397	CbGbCtD
Mycophenolate mofetil—SLCO1B1—Methotrexate—urinary bladder cancer	0.0105	0.033	CbGbCtD
Mycophenolate mofetil—ALB—Fluorouracil—urinary bladder cancer	0.0104	0.0328	CbGbCtD
Mycophenolate mofetil—CYP3A4—Thiotepa—urinary bladder cancer	0.01	0.0316	CbGbCtD
Mycophenolate mofetil—ABCC2—Doxorubicin—urinary bladder cancer	0.0095	0.0299	CbGbCtD
Mycophenolate mofetil—ABCC2—Methotrexate—urinary bladder cancer	0.00921	0.029	CbGbCtD
Mycophenolate mofetil—ABCG2—Doxorubicin—urinary bladder cancer	0.00859	0.0271	CbGbCtD
Mycophenolate mofetil—ABCG2—Methotrexate—urinary bladder cancer	0.00832	0.0262	CbGbCtD
Mycophenolate mofetil—CYP2C8—Fluorouracil—urinary bladder cancer	0.00804	0.0253	CbGbCtD
Mycophenolate mofetil—CYP3A5—Etoposide—urinary bladder cancer	0.00698	0.022	CbGbCtD
Mycophenolate mofetil—CYP2C8—Etoposide—urinary bladder cancer	0.00671	0.0211	CbGbCtD
Mycophenolate mofetil—ABCB1—Gemcitabine—urinary bladder cancer	0.00636	0.02	CbGbCtD
Mycophenolate mofetil—ALB—Methotrexate—urinary bladder cancer	0.00574	0.0181	CbGbCtD
Mycophenolate mofetil—ABCB1—Cisplatin—urinary bladder cancer	0.00462	0.0146	CbGbCtD
Mycophenolate mofetil—ABCB1—Etoposide—urinary bladder cancer	0.00454	0.0143	CbGbCtD
Mycophenolate mofetil—Mycophenolic acid—UGT2B7—urinary bladder cancer	0.00428	1	CrCbGaD
Mycophenolate mofetil—ABCB1—Doxorubicin—urinary bladder cancer	0.0031	0.00976	CbGbCtD
Mycophenolate mofetil—ABCB1—Methotrexate—urinary bladder cancer	0.003	0.00945	CbGbCtD
Mycophenolate mofetil—UGT1A1—urine—urinary bladder cancer	0.00281	0.0585	CbGeAlD
Mycophenolate mofetil—UGT1A6—prostate gland—urinary bladder cancer	0.00273	0.0568	CbGeAlD
Mycophenolate mofetil—CYP3A4—Etoposide—urinary bladder cancer	0.00272	0.00857	CbGbCtD
Mycophenolate mofetil—UGT1A7—renal system—urinary bladder cancer	0.00239	0.0498	CbGeAlD
Mycophenolate mofetil—UGT1A10—renal system—urinary bladder cancer	0.002	0.0416	CbGeAlD
Mycophenolate mofetil—CYP3A4—Doxorubicin—urinary bladder cancer	0.00186	0.00585	CbGbCtD
Mycophenolate mofetil—UGT1A8—renal system—urinary bladder cancer	0.00158	0.0329	CbGeAlD
Mycophenolate mofetil—IMPDH2—prostate gland—urinary bladder cancer	0.00131	0.0272	CbGeAlD
Mycophenolate mofetil—IMPDH1—prostate gland—urinary bladder cancer	0.0013	0.027	CbGeAlD
Mycophenolate mofetil—UGT2B7—prostate gland—urinary bladder cancer	0.00119	0.0247	CbGeAlD
Mycophenolate mofetil—CES2—prostate gland—urinary bladder cancer	0.00119	0.0247	CbGeAlD
Mycophenolate mofetil—IMPDH2—seminal vesicle—urinary bladder cancer	0.00111	0.023	CbGeAlD
Mycophenolate mofetil—IMPDH1—seminal vesicle—urinary bladder cancer	0.0011	0.0229	CbGeAlD
Mycophenolate mofetil—UGT1A1—prostate gland—urinary bladder cancer	0.00101	0.021	CbGeAlD
Mycophenolate mofetil—CES2—seminal vesicle—urinary bladder cancer	0.001	0.0209	CbGeAlD
Mycophenolate mofetil—UGT1A9—renal system—urinary bladder cancer	0.001	0.0209	CbGeAlD
Mycophenolate mofetil—CES1—prostate gland—urinary bladder cancer	0.000978	0.0204	CbGeAlD
Mycophenolate mofetil—IMPDH2—smooth muscle tissue—urinary bladder cancer	0.000925	0.0193	CbGeAlD
Mycophenolate mofetil—IMPDH1—smooth muscle tissue—urinary bladder cancer	0.00092	0.0191	CbGeAlD
Mycophenolate mofetil—CYP3A4—urine—urinary bladder cancer	0.000902	0.0188	CbGeAlD
Mycophenolate mofetil—IMPDH2—renal system—urinary bladder cancer	0.000891	0.0185	CbGeAlD
Mycophenolate mofetil—IMPDH1—renal system—urinary bladder cancer	0.000885	0.0184	CbGeAlD
Mycophenolate mofetil—IMPDH2—urethra—urinary bladder cancer	0.000875	0.0182	CbGeAlD
Mycophenolate mofetil—IMPDH1—urethra—urinary bladder cancer	0.00087	0.0181	CbGeAlD
Mycophenolate mofetil—CES2—smooth muscle tissue—urinary bladder cancer	0.000841	0.0175	CbGeAlD
Mycophenolate mofetil—CES2—renal system—urinary bladder cancer	0.00081	0.0168	CbGeAlD
Mycophenolate mofetil—UGT2B7—renal system—urinary bladder cancer	0.00081	0.0168	CbGeAlD
Mycophenolate mofetil—CES2—urethra—urinary bladder cancer	0.000795	0.0165	CbGeAlD
Mycophenolate mofetil—SLCO1B3—vagina—urinary bladder cancer	0.000717	0.0149	CbGeAlD
Mycophenolate mofetil—IMPDH2—female reproductive system—urinary bladder cancer	0.000713	0.0148	CbGeAlD
Mycophenolate mofetil—IMPDH1—female reproductive system—urinary bladder cancer	0.000709	0.0147	CbGeAlD
Mycophenolate mofetil—UGT1A1—renal system—urinary bladder cancer	0.000688	0.0143	CbGeAlD
Mycophenolate mofetil—UGT2B7—female reproductive system—urinary bladder cancer	0.000648	0.0135	CbGeAlD
Mycophenolate mofetil—CES2—female reproductive system—urinary bladder cancer	0.000648	0.0135	CbGeAlD
Mycophenolate mofetil—IMPDH2—vagina—urinary bladder cancer	0.000645	0.0134	CbGeAlD
Mycophenolate mofetil—IMPDH1—vagina—urinary bladder cancer	0.000641	0.0133	CbGeAlD
Mycophenolate mofetil—ABCC2—prostate gland—urinary bladder cancer	0.000637	0.0133	CbGeAlD
Mycophenolate mofetil—CES2—vagina—urinary bladder cancer	0.000586	0.0122	CbGeAlD
Mycophenolate mofetil—SLCO1B1—renal system—urinary bladder cancer	0.000573	0.0119	CbGeAlD
Mycophenolate mofetil—CES1—female reproductive system—urinary bladder cancer	0.000534	0.0111	CbGeAlD
Mycophenolate mofetil—ABCG2—prostate gland—urinary bladder cancer	0.000465	0.00967	CbGeAlD
Mycophenolate mofetil—SLCO1B1—female reproductive system—urinary bladder cancer	0.000459	0.00954	CbGeAlD
Mycophenolate mofetil—ABCC2—renal system—urinary bladder cancer	0.000434	0.00903	CbGeAlD
Mycophenolate mofetil—CYP3A5—prostate gland—urinary bladder cancer	0.000431	0.00897	CbGeAlD
Mycophenolate mofetil—IMPDH2—lymph node—urinary bladder cancer	0.000417	0.00868	CbGeAlD
Mycophenolate mofetil—IMPDH1—lymph node—urinary bladder cancer	0.000415	0.00863	CbGeAlD
Mycophenolate mofetil—ABCG2—seminal vesicle—urinary bladder cancer	0.000393	0.00818	CbGeAlD
Mycophenolate mofetil—CES2—lymph node—urinary bladder cancer	0.000379	0.00789	CbGeAlD
Mycophenolate mofetil—ABCC2—female reproductive system—urinary bladder cancer	0.000348	0.00724	CbGeAlD
Mycophenolate mofetil—CYP2C8—renal system—urinary bladder cancer	0.000326	0.00678	CbGeAlD
Mycophenolate mofetil—CES1—lymph node—urinary bladder cancer	0.000312	0.0065	CbGeAlD
Mycophenolate mofetil—ABCG2—urethra—urinary bladder cancer	0.000311	0.00647	CbGeAlD
Mycophenolate mofetil—CYP3A5—renal system—urinary bladder cancer	0.000294	0.00612	CbGeAlD
Mycophenolate mofetil—CYP2C8—female reproductive system—urinary bladder cancer	0.000261	0.00543	CbGeAlD
Mycophenolate mofetil—CYP2C8—vagina—urinary bladder cancer	0.000236	0.00491	CbGeAlD
Mycophenolate mofetil—ABCG2—vagina—urinary bladder cancer	0.000229	0.00477	CbGeAlD
Mycophenolate mofetil—ABCB1—prostate gland—urinary bladder cancer	0.000229	0.00477	CbGeAlD
Mycophenolate mofetil—CYP3A4—renal system—urinary bladder cancer	0.000221	0.00459	CbGeAlD
Mycophenolate mofetil—ALB—lymph node—urinary bladder cancer	0.000217	0.00452	CbGeAlD
Mycophenolate mofetil—CYP3A5—vagina—urinary bladder cancer	0.000213	0.00443	CbGeAlD
Mycophenolate mofetil—ABCC2—lymph node—urinary bladder cancer	0.000203	0.00423	CbGeAlD
Mycophenolate mofetil—ABCB1—seminal vesicle—urinary bladder cancer	0.000194	0.00403	CbGeAlD
Mycophenolate mofetil—CYP3A4—female reproductive system—urinary bladder cancer	0.000177	0.00368	CbGeAlD
Mycophenolate mofetil—ABCB1—epithelium—urinary bladder cancer	0.000168	0.0035	CbGeAlD
Mycophenolate mofetil—ABCB1—renal system—urinary bladder cancer	0.000156	0.00325	CbGeAlD
Mycophenolate mofetil—ABCB1—urethra—urinary bladder cancer	0.000153	0.00319	CbGeAlD
Mycophenolate mofetil—ABCG2—lymph node—urinary bladder cancer	0.000148	0.00309	CbGeAlD
Mycophenolate mofetil—ABCB1—female reproductive system—urinary bladder cancer	0.000125	0.0026	CbGeAlD
Mycophenolate mofetil—ABCB1—vagina—urinary bladder cancer	0.000113	0.00235	CbGeAlD
Mycophenolate mofetil—ABCB1—lymph node—urinary bladder cancer	7.32e-05	0.00152	CbGeAlD
Mycophenolate mofetil—Hypoaesthesia—Epirubicin—urinary bladder cancer	3.47e-05	0.000271	CcSEcCtD
Mycophenolate mofetil—Asthenia—Cisplatin—urinary bladder cancer	3.46e-05	0.00027	CcSEcCtD
Mycophenolate mofetil—Pharyngitis—Epirubicin—urinary bladder cancer	3.46e-05	0.00027	CcSEcCtD
Mycophenolate mofetil—Cardiac disorder—Methotrexate—urinary bladder cancer	3.46e-05	0.00027	CcSEcCtD
Mycophenolate mofetil—Sweating—Doxorubicin—urinary bladder cancer	3.45e-05	0.000269	CcSEcCtD
Mycophenolate mofetil—Urinary tract disorder—Epirubicin—urinary bladder cancer	3.45e-05	0.000269	CcSEcCtD
Mycophenolate mofetil—Oedema peripheral—Epirubicin—urinary bladder cancer	3.44e-05	0.000268	CcSEcCtD
Mycophenolate mofetil—Haematuria—Doxorubicin—urinary bladder cancer	3.43e-05	0.000267	CcSEcCtD
Mycophenolate mofetil—Connective tissue disorder—Epirubicin—urinary bladder cancer	3.43e-05	0.000267	CcSEcCtD
Mycophenolate mofetil—Urethral disorder—Epirubicin—urinary bladder cancer	3.42e-05	0.000267	CcSEcCtD
Mycophenolate mofetil—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	3.4e-05	0.000265	CcSEcCtD
Mycophenolate mofetil—Epistaxis—Doxorubicin—urinary bladder cancer	3.39e-05	0.000264	CcSEcCtD
Mycophenolate mofetil—Angiopathy—Methotrexate—urinary bladder cancer	3.38e-05	0.000264	CcSEcCtD
Mycophenolate mofetil—Sinusitis—Doxorubicin—urinary bladder cancer	3.37e-05	0.000263	CcSEcCtD
Mycophenolate mofetil—Dizziness—Fluorouracil—urinary bladder cancer	3.37e-05	0.000262	CcSEcCtD
Mycophenolate mofetil—Visual impairment—Epirubicin—urinary bladder cancer	3.36e-05	0.000262	CcSEcCtD
Mycophenolate mofetil—Mediastinal disorder—Methotrexate—urinary bladder cancer	3.36e-05	0.000262	CcSEcCtD
Mycophenolate mofetil—Agranulocytosis—Doxorubicin—urinary bladder cancer	3.36e-05	0.000262	CcSEcCtD
Mycophenolate mofetil—Chills—Methotrexate—urinary bladder cancer	3.35e-05	0.000261	CcSEcCtD
Mycophenolate mofetil—Diarrhoea—Cisplatin—urinary bladder cancer	3.3e-05	0.000257	CcSEcCtD
Mycophenolate mofetil—Alopecia—Methotrexate—urinary bladder cancer	3.29e-05	0.000257	CcSEcCtD
Mycophenolate mofetil—Vomiting—Gemcitabine—urinary bladder cancer	3.29e-05	0.000257	CcSEcCtD
Mycophenolate mofetil—Bradycardia—Doxorubicin—urinary bladder cancer	3.29e-05	0.000256	CcSEcCtD
Mycophenolate mofetil—Mental disorder—Methotrexate—urinary bladder cancer	3.27e-05	0.000255	CcSEcCtD
Mycophenolate mofetil—Rash—Gemcitabine—urinary bladder cancer	3.27e-05	0.000254	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Gemcitabine—urinary bladder cancer	3.26e-05	0.000254	CcSEcCtD
Mycophenolate mofetil—Eye disorder—Epirubicin—urinary bladder cancer	3.26e-05	0.000254	CcSEcCtD
Mycophenolate mofetil—Hypersensitivity—Etoposide—urinary bladder cancer	3.26e-05	0.000254	CcSEcCtD
Mycophenolate mofetil—Tinnitus—Epirubicin—urinary bladder cancer	3.25e-05	0.000254	CcSEcCtD
Mycophenolate mofetil—Malnutrition—Methotrexate—urinary bladder cancer	3.25e-05	0.000253	CcSEcCtD
Mycophenolate mofetil—Haemoglobin—Doxorubicin—urinary bladder cancer	3.24e-05	0.000253	CcSEcCtD
Mycophenolate mofetil—Headache—Gemcitabine—urinary bladder cancer	3.24e-05	0.000253	CcSEcCtD
Mycophenolate mofetil—Cardiac disorder—Epirubicin—urinary bladder cancer	3.24e-05	0.000252	CcSEcCtD
Mycophenolate mofetil—Vomiting—Fluorouracil—urinary bladder cancer	3.24e-05	0.000252	CcSEcCtD
Mycophenolate mofetil—Rhinitis—Doxorubicin—urinary bladder cancer	3.24e-05	0.000252	CcSEcCtD
Mycophenolate mofetil—Hepatitis—Doxorubicin—urinary bladder cancer	3.23e-05	0.000252	CcSEcCtD
Mycophenolate mofetil—Haemorrhage—Doxorubicin—urinary bladder cancer	3.23e-05	0.000252	CcSEcCtD
Mycophenolate mofetil—Hypoaesthesia—Doxorubicin—urinary bladder cancer	3.21e-05	0.00025	CcSEcCtD
Mycophenolate mofetil—Rash—Fluorouracil—urinary bladder cancer	3.21e-05	0.00025	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Fluorouracil—urinary bladder cancer	3.21e-05	0.00025	CcSEcCtD
Mycophenolate mofetil—Pharyngitis—Doxorubicin—urinary bladder cancer	3.2e-05	0.00025	CcSEcCtD
Mycophenolate mofetil—Headache—Fluorouracil—urinary bladder cancer	3.19e-05	0.000249	CcSEcCtD
Mycophenolate mofetil—Urinary tract disorder—Doxorubicin—urinary bladder cancer	3.19e-05	0.000248	CcSEcCtD
Mycophenolate mofetil—Oedema peripheral—Doxorubicin—urinary bladder cancer	3.18e-05	0.000248	CcSEcCtD
Mycophenolate mofetil—Dysgeusia—Methotrexate—urinary bladder cancer	3.18e-05	0.000248	CcSEcCtD
Mycophenolate mofetil—Asthenia—Etoposide—urinary bladder cancer	3.17e-05	0.000247	CcSEcCtD
Mycophenolate mofetil—Connective tissue disorder—Doxorubicin—urinary bladder cancer	3.17e-05	0.000247	CcSEcCtD
Mycophenolate mofetil—Angiopathy—Epirubicin—urinary bladder cancer	3.17e-05	0.000247	CcSEcCtD
Mycophenolate mofetil—Urethral disorder—Doxorubicin—urinary bladder cancer	3.16e-05	0.000247	CcSEcCtD
Mycophenolate mofetil—Mediastinal disorder—Epirubicin—urinary bladder cancer	3.14e-05	0.000245	CcSEcCtD
Mycophenolate mofetil—Back pain—Methotrexate—urinary bladder cancer	3.14e-05	0.000245	CcSEcCtD
Mycophenolate mofetil—Chills—Epirubicin—urinary bladder cancer	3.13e-05	0.000244	CcSEcCtD
Mycophenolate mofetil—Pruritus—Etoposide—urinary bladder cancer	3.13e-05	0.000244	CcSEcCtD
Mycophenolate mofetil—Arrhythmia—Epirubicin—urinary bladder cancer	3.12e-05	0.000243	CcSEcCtD
Mycophenolate mofetil—Visual impairment—Doxorubicin—urinary bladder cancer	3.11e-05	0.000242	CcSEcCtD
Mycophenolate mofetil—Alopecia—Epirubicin—urinary bladder cancer	3.08e-05	0.00024	CcSEcCtD
Mycophenolate mofetil—Nausea—Gemcitabine—urinary bladder cancer	3.08e-05	0.00024	CcSEcCtD
Mycophenolate mofetil—Vomiting—Cisplatin—urinary bladder cancer	3.07e-05	0.000239	CcSEcCtD
Mycophenolate mofetil—Mental disorder—Epirubicin—urinary bladder cancer	3.06e-05	0.000238	CcSEcCtD
Mycophenolate mofetil—Rash—Cisplatin—urinary bladder cancer	3.04e-05	0.000237	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Cisplatin—urinary bladder cancer	3.04e-05	0.000237	CcSEcCtD
Mycophenolate mofetil—Malnutrition—Epirubicin—urinary bladder cancer	3.04e-05	0.000237	CcSEcCtD
Mycophenolate mofetil—Diarrhoea—Etoposide—urinary bladder cancer	3.03e-05	0.000236	CcSEcCtD
Mycophenolate mofetil—Nausea—Fluorouracil—urinary bladder cancer	3.02e-05	0.000236	CcSEcCtD
Mycophenolate mofetil—Eye disorder—Doxorubicin—urinary bladder cancer	3.02e-05	0.000235	CcSEcCtD
Mycophenolate mofetil—Ill-defined disorder—Methotrexate—urinary bladder cancer	3.01e-05	0.000235	CcSEcCtD
Mycophenolate mofetil—Tinnitus—Doxorubicin—urinary bladder cancer	3.01e-05	0.000235	CcSEcCtD
Mycophenolate mofetil—Anaemia—Methotrexate—urinary bladder cancer	3e-05	0.000234	CcSEcCtD
Mycophenolate mofetil—Cardiac disorder—Doxorubicin—urinary bladder cancer	3e-05	0.000234	CcSEcCtD
Mycophenolate mofetil—Flatulence—Epirubicin—urinary bladder cancer	2.99e-05	0.000233	CcSEcCtD
Mycophenolate mofetil—Tension—Epirubicin—urinary bladder cancer	2.98e-05	0.000232	CcSEcCtD
Mycophenolate mofetil—Dysgeusia—Epirubicin—urinary bladder cancer	2.97e-05	0.000232	CcSEcCtD
Mycophenolate mofetil—Nervousness—Epirubicin—urinary bladder cancer	2.95e-05	0.00023	CcSEcCtD
Mycophenolate mofetil—Back pain—Epirubicin—urinary bladder cancer	2.94e-05	0.000229	CcSEcCtD
Mycophenolate mofetil—Angiopathy—Doxorubicin—urinary bladder cancer	2.93e-05	0.000228	CcSEcCtD
Mycophenolate mofetil—Malaise—Methotrexate—urinary bladder cancer	2.93e-05	0.000228	CcSEcCtD
Mycophenolate mofetil—Dizziness—Etoposide—urinary bladder cancer	2.92e-05	0.000228	CcSEcCtD
Mycophenolate mofetil—Muscle spasms—Epirubicin—urinary bladder cancer	2.92e-05	0.000228	CcSEcCtD
Mycophenolate mofetil—Vertigo—Methotrexate—urinary bladder cancer	2.92e-05	0.000227	CcSEcCtD
Mycophenolate mofetil—Mediastinal disorder—Doxorubicin—urinary bladder cancer	2.91e-05	0.000227	CcSEcCtD
Mycophenolate mofetil—Leukopenia—Methotrexate—urinary bladder cancer	2.91e-05	0.000226	CcSEcCtD
Mycophenolate mofetil—Chills—Doxorubicin—urinary bladder cancer	2.9e-05	0.000226	CcSEcCtD
Mycophenolate mofetil—Arrhythmia—Doxorubicin—urinary bladder cancer	2.88e-05	0.000225	CcSEcCtD
Mycophenolate mofetil—Nausea—Cisplatin—urinary bladder cancer	2.87e-05	0.000223	CcSEcCtD
Mycophenolate mofetil—Alopecia—Doxorubicin—urinary bladder cancer	2.85e-05	0.000222	CcSEcCtD
Mycophenolate mofetil—Cough—Methotrexate—urinary bladder cancer	2.83e-05	0.000221	CcSEcCtD
Mycophenolate mofetil—Mental disorder—Doxorubicin—urinary bladder cancer	2.83e-05	0.00022	CcSEcCtD
Mycophenolate mofetil—Ill-defined disorder—Epirubicin—urinary bladder cancer	2.82e-05	0.00022	CcSEcCtD
Mycophenolate mofetil—Convulsion—Methotrexate—urinary bladder cancer	2.81e-05	0.000219	CcSEcCtD
Mycophenolate mofetil—Vomiting—Etoposide—urinary bladder cancer	2.81e-05	0.000219	CcSEcCtD
Mycophenolate mofetil—Malnutrition—Doxorubicin—urinary bladder cancer	2.81e-05	0.000219	CcSEcCtD
Mycophenolate mofetil—Anaemia—Epirubicin—urinary bladder cancer	2.81e-05	0.000219	CcSEcCtD
Mycophenolate mofetil—Agitation—Epirubicin—urinary bladder cancer	2.79e-05	0.000218	CcSEcCtD
Mycophenolate mofetil—Rash—Etoposide—urinary bladder cancer	2.79e-05	0.000217	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Etoposide—urinary bladder cancer	2.79e-05	0.000217	CcSEcCtD
Mycophenolate mofetil—Headache—Etoposide—urinary bladder cancer	2.77e-05	0.000216	CcSEcCtD
Mycophenolate mofetil—Flatulence—Doxorubicin—urinary bladder cancer	2.77e-05	0.000216	CcSEcCtD
Mycophenolate mofetil—Arthralgia—Methotrexate—urinary bladder cancer	2.76e-05	0.000215	CcSEcCtD
Mycophenolate mofetil—Myalgia—Methotrexate—urinary bladder cancer	2.76e-05	0.000215	CcSEcCtD
Mycophenolate mofetil—Chest pain—Methotrexate—urinary bladder cancer	2.76e-05	0.000215	CcSEcCtD
Mycophenolate mofetil—Tension—Doxorubicin—urinary bladder cancer	2.76e-05	0.000215	CcSEcCtD
Mycophenolate mofetil—Dysgeusia—Doxorubicin—urinary bladder cancer	2.75e-05	0.000214	CcSEcCtD
Mycophenolate mofetil—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	2.74e-05	0.000214	CcSEcCtD
Mycophenolate mofetil—Malaise—Epirubicin—urinary bladder cancer	2.74e-05	0.000213	CcSEcCtD
Mycophenolate mofetil—Discomfort—Methotrexate—urinary bladder cancer	2.73e-05	0.000213	CcSEcCtD
Mycophenolate mofetil—Nervousness—Doxorubicin—urinary bladder cancer	2.73e-05	0.000213	CcSEcCtD
Mycophenolate mofetil—Vertigo—Epirubicin—urinary bladder cancer	2.73e-05	0.000213	CcSEcCtD
Mycophenolate mofetil—Syncope—Epirubicin—urinary bladder cancer	2.72e-05	0.000212	CcSEcCtD
Mycophenolate mofetil—Leukopenia—Epirubicin—urinary bladder cancer	2.72e-05	0.000212	CcSEcCtD
Mycophenolate mofetil—Back pain—Doxorubicin—urinary bladder cancer	2.72e-05	0.000212	CcSEcCtD
Mycophenolate mofetil—Muscle spasms—Doxorubicin—urinary bladder cancer	2.7e-05	0.000211	CcSEcCtD
Mycophenolate mofetil—Palpitations—Epirubicin—urinary bladder cancer	2.68e-05	0.000209	CcSEcCtD
Mycophenolate mofetil—Confusional state—Methotrexate—urinary bladder cancer	2.67e-05	0.000208	CcSEcCtD
Mycophenolate mofetil—Loss of consciousness—Epirubicin—urinary bladder cancer	2.67e-05	0.000208	CcSEcCtD
Mycophenolate mofetil—Cough—Epirubicin—urinary bladder cancer	2.65e-05	0.000207	CcSEcCtD
Mycophenolate mofetil—Anaphylactic shock—Methotrexate—urinary bladder cancer	2.65e-05	0.000206	CcSEcCtD
Mycophenolate mofetil—Convulsion—Epirubicin—urinary bladder cancer	2.63e-05	0.000205	CcSEcCtD
Mycophenolate mofetil—Infection—Methotrexate—urinary bladder cancer	2.63e-05	0.000205	CcSEcCtD
Mycophenolate mofetil—Nausea—Etoposide—urinary bladder cancer	2.63e-05	0.000205	CcSEcCtD
Mycophenolate mofetil—Hypertension—Epirubicin—urinary bladder cancer	2.62e-05	0.000204	CcSEcCtD
Mycophenolate mofetil—Ill-defined disorder—Doxorubicin—urinary bladder cancer	2.61e-05	0.000203	CcSEcCtD
Mycophenolate mofetil—Nervous system disorder—Methotrexate—urinary bladder cancer	2.6e-05	0.000202	CcSEcCtD
Mycophenolate mofetil—Anaemia—Doxorubicin—urinary bladder cancer	2.6e-05	0.000202	CcSEcCtD
Mycophenolate mofetil—Thrombocytopenia—Methotrexate—urinary bladder cancer	2.59e-05	0.000202	CcSEcCtD
Mycophenolate mofetil—Chest pain—Epirubicin—urinary bladder cancer	2.59e-05	0.000202	CcSEcCtD
Mycophenolate mofetil—Myalgia—Epirubicin—urinary bladder cancer	2.59e-05	0.000202	CcSEcCtD
Mycophenolate mofetil—Arthralgia—Epirubicin—urinary bladder cancer	2.59e-05	0.000202	CcSEcCtD
Mycophenolate mofetil—Agitation—Doxorubicin—urinary bladder cancer	2.58e-05	0.000201	CcSEcCtD
Mycophenolate mofetil—Anxiety—Epirubicin—urinary bladder cancer	2.58e-05	0.000201	CcSEcCtD
Mycophenolate mofetil—Skin disorder—Methotrexate—urinary bladder cancer	2.57e-05	0.000201	CcSEcCtD
Mycophenolate mofetil—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	2.57e-05	0.0002	CcSEcCtD
Mycophenolate mofetil—Hyperhidrosis—Methotrexate—urinary bladder cancer	2.56e-05	0.0002	CcSEcCtD
Mycophenolate mofetil—Discomfort—Epirubicin—urinary bladder cancer	2.55e-05	0.000199	CcSEcCtD
Mycophenolate mofetil—Malaise—Doxorubicin—urinary bladder cancer	2.53e-05	0.000198	CcSEcCtD
Mycophenolate mofetil—Dry mouth—Epirubicin—urinary bladder cancer	2.53e-05	0.000197	CcSEcCtD
Mycophenolate mofetil—Vertigo—Doxorubicin—urinary bladder cancer	2.52e-05	0.000197	CcSEcCtD
Mycophenolate mofetil—Anorexia—Methotrexate—urinary bladder cancer	2.52e-05	0.000197	CcSEcCtD
Mycophenolate mofetil—Syncope—Doxorubicin—urinary bladder cancer	2.52e-05	0.000196	CcSEcCtD
Mycophenolate mofetil—Leukopenia—Doxorubicin—urinary bladder cancer	2.52e-05	0.000196	CcSEcCtD
Mycophenolate mofetil—Confusional state—Epirubicin—urinary bladder cancer	2.5e-05	0.000195	CcSEcCtD
Mycophenolate mofetil—Palpitations—Doxorubicin—urinary bladder cancer	2.48e-05	0.000194	CcSEcCtD
Mycophenolate mofetil—Anaphylactic shock—Epirubicin—urinary bladder cancer	2.48e-05	0.000193	CcSEcCtD
Mycophenolate mofetil—Oedema—Epirubicin—urinary bladder cancer	2.48e-05	0.000193	CcSEcCtD
Mycophenolate mofetil—Hypotension—Methotrexate—urinary bladder cancer	2.48e-05	0.000193	CcSEcCtD
Mycophenolate mofetil—Loss of consciousness—Doxorubicin—urinary bladder cancer	2.47e-05	0.000193	CcSEcCtD
Mycophenolate mofetil—Infection—Epirubicin—urinary bladder cancer	2.46e-05	0.000192	CcSEcCtD
Mycophenolate mofetil—Cough—Doxorubicin—urinary bladder cancer	2.45e-05	0.000191	CcSEcCtD
Mycophenolate mofetil—Shock—Epirubicin—urinary bladder cancer	2.44e-05	0.00019	CcSEcCtD
Mycophenolate mofetil—Convulsion—Doxorubicin—urinary bladder cancer	2.43e-05	0.00019	CcSEcCtD
Mycophenolate mofetil—Nervous system disorder—Epirubicin—urinary bladder cancer	2.43e-05	0.000189	CcSEcCtD
Mycophenolate mofetil—Thrombocytopenia—Epirubicin—urinary bladder cancer	2.43e-05	0.000189	CcSEcCtD
Mycophenolate mofetil—Hypertension—Doxorubicin—urinary bladder cancer	2.43e-05	0.000189	CcSEcCtD
Mycophenolate mofetil—Tachycardia—Epirubicin—urinary bladder cancer	2.42e-05	0.000189	CcSEcCtD
Mycophenolate mofetil—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	2.41e-05	0.000188	CcSEcCtD
Mycophenolate mofetil—Skin disorder—Epirubicin—urinary bladder cancer	2.41e-05	0.000188	CcSEcCtD
Mycophenolate mofetil—Hyperhidrosis—Epirubicin—urinary bladder cancer	2.4e-05	0.000187	CcSEcCtD
Mycophenolate mofetil—Insomnia—Methotrexate—urinary bladder cancer	2.4e-05	0.000187	CcSEcCtD
Mycophenolate mofetil—Myalgia—Doxorubicin—urinary bladder cancer	2.39e-05	0.000186	CcSEcCtD
Mycophenolate mofetil—Chest pain—Doxorubicin—urinary bladder cancer	2.39e-05	0.000186	CcSEcCtD
Mycophenolate mofetil—Arthralgia—Doxorubicin—urinary bladder cancer	2.39e-05	0.000186	CcSEcCtD
Mycophenolate mofetil—Anxiety—Doxorubicin—urinary bladder cancer	2.38e-05	0.000186	CcSEcCtD
Mycophenolate mofetil—Paraesthesia—Methotrexate—urinary bladder cancer	2.38e-05	0.000185	CcSEcCtD
Mycophenolate mofetil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	2.38e-05	0.000185	CcSEcCtD
Mycophenolate mofetil—Discomfort—Doxorubicin—urinary bladder cancer	2.36e-05	0.000184	CcSEcCtD
Mycophenolate mofetil—Anorexia—Epirubicin—urinary bladder cancer	2.36e-05	0.000184	CcSEcCtD
Mycophenolate mofetil—Dyspnoea—Methotrexate—urinary bladder cancer	2.36e-05	0.000184	CcSEcCtD
Mycophenolate mofetil—Somnolence—Methotrexate—urinary bladder cancer	2.35e-05	0.000184	CcSEcCtD
Mycophenolate mofetil—Dry mouth—Doxorubicin—urinary bladder cancer	2.34e-05	0.000182	CcSEcCtD
Mycophenolate mofetil—Dyspepsia—Methotrexate—urinary bladder cancer	2.33e-05	0.000182	CcSEcCtD
Mycophenolate mofetil—Hypotension—Epirubicin—urinary bladder cancer	2.32e-05	0.000181	CcSEcCtD
Mycophenolate mofetil—Confusional state—Doxorubicin—urinary bladder cancer	2.31e-05	0.00018	CcSEcCtD
Mycophenolate mofetil—Decreased appetite—Methotrexate—urinary bladder cancer	2.3e-05	0.000179	CcSEcCtD
Mycophenolate mofetil—Anaphylactic shock—Doxorubicin—urinary bladder cancer	2.29e-05	0.000179	CcSEcCtD
Mycophenolate mofetil—Oedema—Doxorubicin—urinary bladder cancer	2.29e-05	0.000179	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	2.29e-05	0.000178	CcSEcCtD
Mycophenolate mofetil—Infection—Doxorubicin—urinary bladder cancer	2.28e-05	0.000178	CcSEcCtD
Mycophenolate mofetil—Pain—Methotrexate—urinary bladder cancer	2.27e-05	0.000177	CcSEcCtD
Mycophenolate mofetil—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	2.26e-05	0.000176	CcSEcCtD
Mycophenolate mofetil—Shock—Doxorubicin—urinary bladder cancer	2.26e-05	0.000176	CcSEcCtD
Mycophenolate mofetil—Nervous system disorder—Doxorubicin—urinary bladder cancer	2.25e-05	0.000175	CcSEcCtD
Mycophenolate mofetil—Thrombocytopenia—Doxorubicin—urinary bladder cancer	2.25e-05	0.000175	CcSEcCtD
Mycophenolate mofetil—Insomnia—Epirubicin—urinary bladder cancer	2.24e-05	0.000175	CcSEcCtD
Mycophenolate mofetil—Tachycardia—Doxorubicin—urinary bladder cancer	2.24e-05	0.000174	CcSEcCtD
Mycophenolate mofetil—Skin disorder—Doxorubicin—urinary bladder cancer	2.23e-05	0.000174	CcSEcCtD
Mycophenolate mofetil—Paraesthesia—Epirubicin—urinary bladder cancer	2.23e-05	0.000173	CcSEcCtD
Mycophenolate mofetil—Hyperhidrosis—Doxorubicin—urinary bladder cancer	2.22e-05	0.000173	CcSEcCtD
Mycophenolate mofetil—Dyspnoea—Epirubicin—urinary bladder cancer	2.21e-05	0.000172	CcSEcCtD
Mycophenolate mofetil—Somnolence—Epirubicin—urinary bladder cancer	2.2e-05	0.000172	CcSEcCtD
Mycophenolate mofetil—Anorexia—Doxorubicin—urinary bladder cancer	2.19e-05	0.00017	CcSEcCtD
Mycophenolate mofetil—Feeling abnormal—Methotrexate—urinary bladder cancer	2.18e-05	0.00017	CcSEcCtD
Mycophenolate mofetil—Dyspepsia—Epirubicin—urinary bladder cancer	2.18e-05	0.00017	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal pain—Methotrexate—urinary bladder cancer	2.17e-05	0.000169	CcSEcCtD
Mycophenolate mofetil—Decreased appetite—Epirubicin—urinary bladder cancer	2.15e-05	0.000168	CcSEcCtD
Mycophenolate mofetil—Hypotension—Doxorubicin—urinary bladder cancer	2.14e-05	0.000167	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	2.14e-05	0.000167	CcSEcCtD
Mycophenolate mofetil—Constipation—Epirubicin—urinary bladder cancer	2.12e-05	0.000165	CcSEcCtD
Mycophenolate mofetil—Pain—Epirubicin—urinary bladder cancer	2.12e-05	0.000165	CcSEcCtD
Mycophenolate mofetil—Urticaria—Methotrexate—urinary bladder cancer	2.1e-05	0.000164	CcSEcCtD
Mycophenolate mofetil—Abdominal pain—Methotrexate—urinary bladder cancer	2.09e-05	0.000163	CcSEcCtD
Mycophenolate mofetil—Body temperature increased—Methotrexate—urinary bladder cancer	2.09e-05	0.000163	CcSEcCtD
Mycophenolate mofetil—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	2.09e-05	0.000163	CcSEcCtD
Mycophenolate mofetil—Insomnia—Doxorubicin—urinary bladder cancer	2.07e-05	0.000162	CcSEcCtD
Mycophenolate mofetil—Paraesthesia—Doxorubicin—urinary bladder cancer	2.06e-05	0.000161	CcSEcCtD
Mycophenolate mofetil—Dyspnoea—Doxorubicin—urinary bladder cancer	2.04e-05	0.000159	CcSEcCtD
Mycophenolate mofetil—Feeling abnormal—Epirubicin—urinary bladder cancer	2.04e-05	0.000159	CcSEcCtD
Mycophenolate mofetil—Somnolence—Doxorubicin—urinary bladder cancer	2.04e-05	0.000159	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal pain—Epirubicin—urinary bladder cancer	2.03e-05	0.000158	CcSEcCtD
Mycophenolate mofetil—Dyspepsia—Doxorubicin—urinary bladder cancer	2.02e-05	0.000157	CcSEcCtD
Mycophenolate mofetil—Decreased appetite—Doxorubicin—urinary bladder cancer	1.99e-05	0.000155	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	1.98e-05	0.000154	CcSEcCtD
Mycophenolate mofetil—Urticaria—Epirubicin—urinary bladder cancer	1.97e-05	0.000153	CcSEcCtD
Mycophenolate mofetil—Pain—Doxorubicin—urinary bladder cancer	1.96e-05	0.000153	CcSEcCtD
Mycophenolate mofetil—Constipation—Doxorubicin—urinary bladder cancer	1.96e-05	0.000153	CcSEcCtD
Mycophenolate mofetil—Abdominal pain—Epirubicin—urinary bladder cancer	1.96e-05	0.000153	CcSEcCtD
Mycophenolate mofetil—Body temperature increased—Epirubicin—urinary bladder cancer	1.96e-05	0.000153	CcSEcCtD
Mycophenolate mofetil—Hypersensitivity—Methotrexate—urinary bladder cancer	1.95e-05	0.000152	CcSEcCtD
Mycophenolate mofetil—Asthenia—Methotrexate—urinary bladder cancer	1.9e-05	0.000148	CcSEcCtD
Mycophenolate mofetil—Feeling abnormal—Doxorubicin—urinary bladder cancer	1.89e-05	0.000147	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	1.88e-05	0.000146	CcSEcCtD
Mycophenolate mofetil—Pruritus—Methotrexate—urinary bladder cancer	1.87e-05	0.000146	CcSEcCtD
Mycophenolate mofetil—Hypersensitivity—Epirubicin—urinary bladder cancer	1.83e-05	0.000142	CcSEcCtD
Mycophenolate mofetil—Urticaria—Doxorubicin—urinary bladder cancer	1.82e-05	0.000142	CcSEcCtD
Mycophenolate mofetil—Body temperature increased—Doxorubicin—urinary bladder cancer	1.81e-05	0.000141	CcSEcCtD
Mycophenolate mofetil—Abdominal pain—Doxorubicin—urinary bladder cancer	1.81e-05	0.000141	CcSEcCtD
Mycophenolate mofetil—Diarrhoea—Methotrexate—urinary bladder cancer	1.81e-05	0.000141	CcSEcCtD
Mycophenolate mofetil—Asthenia—Epirubicin—urinary bladder cancer	1.78e-05	0.000139	CcSEcCtD
Mycophenolate mofetil—Pruritus—Epirubicin—urinary bladder cancer	1.75e-05	0.000137	CcSEcCtD
Mycophenolate mofetil—Dizziness—Methotrexate—urinary bladder cancer	1.75e-05	0.000137	CcSEcCtD
Mycophenolate mofetil—Diarrhoea—Epirubicin—urinary bladder cancer	1.7e-05	0.000132	CcSEcCtD
Mycophenolate mofetil—Hypersensitivity—Doxorubicin—urinary bladder cancer	1.69e-05	0.000132	CcSEcCtD
Mycophenolate mofetil—Vomiting—Methotrexate—urinary bladder cancer	1.68e-05	0.000131	CcSEcCtD
Mycophenolate mofetil—Rash—Methotrexate—urinary bladder cancer	1.67e-05	0.00013	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Methotrexate—urinary bladder cancer	1.67e-05	0.00013	CcSEcCtD
Mycophenolate mofetil—Headache—Methotrexate—urinary bladder cancer	1.66e-05	0.000129	CcSEcCtD
Mycophenolate mofetil—Asthenia—Doxorubicin—urinary bladder cancer	1.65e-05	0.000128	CcSEcCtD
Mycophenolate mofetil—Dizziness—Epirubicin—urinary bladder cancer	1.64e-05	0.000128	CcSEcCtD
Mycophenolate mofetil—Pruritus—Doxorubicin—urinary bladder cancer	1.62e-05	0.000126	CcSEcCtD
Mycophenolate mofetil—Vomiting—Epirubicin—urinary bladder cancer	1.58e-05	0.000123	CcSEcCtD
Mycophenolate mofetil—Nausea—Methotrexate—urinary bladder cancer	1.57e-05	0.000123	CcSEcCtD
Mycophenolate mofetil—Diarrhoea—Doxorubicin—urinary bladder cancer	1.57e-05	0.000122	CcSEcCtD
Mycophenolate mofetil—Rash—Epirubicin—urinary bladder cancer	1.56e-05	0.000122	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Epirubicin—urinary bladder cancer	1.56e-05	0.000122	CcSEcCtD
Mycophenolate mofetil—Headache—Epirubicin—urinary bladder cancer	1.55e-05	0.000121	CcSEcCtD
Mycophenolate mofetil—Dizziness—Doxorubicin—urinary bladder cancer	1.52e-05	0.000118	CcSEcCtD
Mycophenolate mofetil—Nausea—Epirubicin—urinary bladder cancer	1.47e-05	0.000115	CcSEcCtD
Mycophenolate mofetil—Vomiting—Doxorubicin—urinary bladder cancer	1.46e-05	0.000114	CcSEcCtD
Mycophenolate mofetil—Rash—Doxorubicin—urinary bladder cancer	1.45e-05	0.000113	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Doxorubicin—urinary bladder cancer	1.44e-05	0.000113	CcSEcCtD
Mycophenolate mofetil—Headache—Doxorubicin—urinary bladder cancer	1.44e-05	0.000112	CcSEcCtD
Mycophenolate mofetil—Nausea—Doxorubicin—urinary bladder cancer	1.36e-05	0.000106	CcSEcCtD
Mycophenolate mofetil—CYP2C8—Metabolism—SLC19A1—urinary bladder cancer	8.3e-06	8.04e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	8.26e-06	8e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—SLC19A1—urinary bladder cancer	8.25e-06	8e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—GSTP1—urinary bladder cancer	8.14e-06	7.89e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—HPGDS—urinary bladder cancer	8.14e-06	7.88e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—ENO2—urinary bladder cancer	8.14e-06	7.88e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—RRM2—urinary bladder cancer	8.14e-06	7.88e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—PRSS3—urinary bladder cancer	8.09e-06	7.84e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	8.09e-06	7.84e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—PRSS3—urinary bladder cancer	8.04e-06	7.79e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A8—Metabolism—EP300—urinary bladder cancer	7.95e-06	7.7e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	7.9e-06	7.66e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—GSTT1—urinary bladder cancer	7.89e-06	7.65e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	7.88e-06	7.63e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCC2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	7.87e-06	7.62e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	7.8e-06	7.56e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	7.77e-06	7.53e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—CYP4B1—urinary bladder cancer	7.66e-06	7.42e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—urinary bladder cancer	7.63e-06	7.39e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—TYMS—urinary bladder cancer	7.57e-06	7.33e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—ENO2—urinary bladder cancer	7.53e-06	7.3e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—HPGDS—urinary bladder cancer	7.53e-06	7.3e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—GSTM1—urinary bladder cancer	7.48e-06	7.25e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—NCOR1—urinary bladder cancer	7.48e-06	7.25e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—TYMP—urinary bladder cancer	7.47e-06	7.24e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	7.39e-06	7.16e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—GSTP1—urinary bladder cancer	7.35e-06	7.12e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—GSTT1—urinary bladder cancer	7.31e-06	7.08e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—SLC19A1—urinary bladder cancer	7.23e-06	7.01e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Platelet activation, signaling and aggregation—IL2—urinary bladder cancer	7.18e-06	6.96e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—GPX1—urinary bladder cancer	7.16e-06	6.94e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—NQO1—urinary bladder cancer	7.16e-06	6.94e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—NQO1—urinary bladder cancer	7.16e-06	6.94e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—PRSS3—urinary bladder cancer	7.05e-06	6.83e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—ERCC2—urinary bladder cancer	7.03e-06	6.82e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A6—Metabolism—PTGS2—urinary bladder cancer	6.97e-06	6.76e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	6.94e-06	6.73e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	6.89e-06	6.68e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	6.84e-06	6.63e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—TYMS—urinary bladder cancer	6.83e-06	6.62e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—NAT2—urinary bladder cancer	6.75e-06	6.54e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—GSTM1—urinary bladder cancer	6.75e-06	6.54e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—NCOR1—urinary bladder cancer	6.75e-06	6.54e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	6.67e-06	6.46e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	6.65e-06	6.45e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—MTHFR—urinary bladder cancer	6.61e-06	6.41e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—NQO1—urinary bladder cancer	6.56e-06	6.36e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	6.49e-06	6.29e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—TYMP—urinary bladder cancer	6.47e-06	6.27e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—GPX1—urinary bladder cancer	6.46e-06	6.26e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	6.45e-06	6.25e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—TYMP—urinary bladder cancer	6.43e-06	6.23e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	6.36e-06	6.17e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—ERCC2—urinary bladder cancer	6.35e-06	6.15e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	6.34e-06	6.15e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Platelet activation, signaling and aggregation—SRC—urinary bladder cancer	6.27e-06	6.07e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	6.21e-06	6.02e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	6.18e-06	5.98e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	6.17e-06	5.98e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A6—Metabolism—PTEN—urinary bladder cancer	6.08e-06	5.89e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—NQO1—urinary bladder cancer	6.07e-06	5.88e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	6.06e-06	5.87e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	6.04e-06	5.86e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—GSTP1—urinary bladder cancer	5.97e-06	5.78e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—GSTP1—urinary bladder cancer	5.97e-06	5.78e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—MTHFR—urinary bladder cancer	5.97e-06	5.78e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—PLAU—urinary bladder cancer	5.91e-06	5.73e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—NAT2—urinary bladder cancer	5.85e-06	5.67e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—RRM2—urinary bladder cancer	5.83e-06	5.65e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—NAT2—urinary bladder cancer	5.82e-06	5.64e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A6—Metabolism—EP300—urinary bladder cancer	5.8e-06	5.62e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	5.78e-06	5.6e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	5.73e-06	5.55e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—NAT1—urinary bladder cancer	5.73e-06	5.55e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—TYMP—urinary bladder cancer	5.63e-06	5.46e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—TYMS—urinary bladder cancer	5.55e-06	5.38e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—TYMS—urinary bladder cancer	5.55e-06	5.38e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	5.55e-06	5.38e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	5.53e-06	5.36e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—NCOR1—urinary bladder cancer	5.49e-06	5.32e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—GSTM1—urinary bladder cancer	5.49e-06	5.32e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—GSTM1—urinary bladder cancer	5.49e-06	5.32e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—NCOR1—urinary bladder cancer	5.49e-06	5.32e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—GSTP1—urinary bladder cancer	5.47e-06	5.3e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	5.41e-06	5.24e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—HPGDS—urinary bladder cancer	5.4e-06	5.23e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—ENO2—urinary bladder cancer	5.4e-06	5.23e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—PPARG—urinary bladder cancer	5.36e-06	5.2e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	5.29e-06	5.13e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—GPX1—urinary bladder cancer	5.25e-06	5.09e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—GPX1—urinary bladder cancer	5.25e-06	5.09e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	5.24e-06	5.08e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—GSTT1—urinary bladder cancer	5.24e-06	5.07e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—ERCC2—urinary bladder cancer	5.16e-06	5e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—ERCC2—urinary bladder cancer	5.16e-06	5e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—CREBBP—urinary bladder cancer	5.15e-06	4.99e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	5.15e-06	4.99e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	5.11e-06	4.95e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—NAT2—urinary bladder cancer	5.1e-06	4.94e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—TYMS—urinary bladder cancer	5.09e-06	4.93e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—GSTP1—urinary bladder cancer	5.07e-06	4.91e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—RRM2—urinary bladder cancer	5.05e-06	4.89e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—NCOR1—urinary bladder cancer	5.03e-06	4.87e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—GSTM1—urinary bladder cancer	5.03e-06	4.87e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—RRM2—urinary bladder cancer	5.02e-06	4.86e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—CREBBP—urinary bladder cancer	4.88e-06	4.73e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—MTHFR—urinary bladder cancer	4.85e-06	4.7e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—MTHFR—urinary bladder cancer	4.85e-06	4.7e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—PPARG—urinary bladder cancer	4.84e-06	4.69e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—IGF1—urinary bladder cancer	4.82e-06	4.67e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—GPX1—urinary bladder cancer	4.81e-06	4.66e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—ERCC2—urinary bladder cancer	4.73e-06	4.58e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	4.72e-06	4.57e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—TYMS—urinary bladder cancer	4.71e-06	4.56e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—HPGDS—urinary bladder cancer	4.68e-06	4.53e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—ENO2—urinary bladder cancer	4.68e-06	4.53e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—NCOR1—urinary bladder cancer	4.65e-06	4.51e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—GSTM1—urinary bladder cancer	4.65e-06	4.51e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—HPGDS—urinary bladder cancer	4.65e-06	4.51e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—ENO2—urinary bladder cancer	4.65e-06	4.51e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	4.65e-06	4.5e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—CREBBP—urinary bladder cancer	4.65e-06	4.5e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	4.62e-06	4.48e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	4.54e-06	4.4e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—GSTT1—urinary bladder cancer	4.53e-06	4.39e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—GSTT1—urinary bladder cancer	4.51e-06	4.37e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	4.47e-06	4.33e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—GPX1—urinary bladder cancer	4.46e-06	4.32e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	4.46e-06	4.32e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—MTHFR—urinary bladder cancer	4.44e-06	4.31e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	4.44e-06	4.3e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—RHOA—urinary bladder cancer	4.41e-06	4.28e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—RRM2—urinary bladder cancer	4.4e-06	4.26e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—ERCC2—urinary bladder cancer	4.38e-06	4.24e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—NQO1—urinary bladder cancer	4.35e-06	4.22e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	4.34e-06	4.21e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	4.22e-06	4.09e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—PTGS2—urinary bladder cancer	4.22e-06	4.09e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—MTHFR—urinary bladder cancer	4.11e-06	3.99e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—HPGDS—urinary bladder cancer	4.07e-06	3.95e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—ENO2—urinary bladder cancer	4.07e-06	3.95e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—GSTT1—urinary bladder cancer	3.95e-06	3.83e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—PPARG—urinary bladder cancer	3.93e-06	3.81e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—PPARG—urinary bladder cancer	3.93e-06	3.81e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—PTGS2—urinary bladder cancer	3.81e-06	3.69e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—CREBBP—urinary bladder cancer	3.78e-06	3.66e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—CREBBP—urinary bladder cancer	3.78e-06	3.66e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—NQO1—urinary bladder cancer	3.77e-06	3.65e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—NQO1—urinary bladder cancer	3.75e-06	3.63e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—IL2—urinary bladder cancer	3.7e-06	3.59e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	3.7e-06	3.58e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—PTEN—urinary bladder cancer	3.68e-06	3.56e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	3.66e-06	3.54e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	3.64e-06	3.52e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—GSTP1—urinary bladder cancer	3.63e-06	3.52e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—PPARG—urinary bladder cancer	3.6e-06	3.49e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—EP300—urinary bladder cancer	3.51e-06	3.4e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—TYMP—urinary bladder cancer	3.47e-06	3.36e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—CREBBP—urinary bladder cancer	3.46e-06	3.35e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—TYMS—urinary bladder cancer	3.37e-06	3.27e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—PPARG—urinary bladder cancer	3.34e-06	3.23e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—GSTM1—urinary bladder cancer	3.33e-06	3.23e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—NCOR1—urinary bladder cancer	3.33e-06	3.23e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—EP300—urinary bladder cancer	3.32e-06	3.22e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—PTEN—urinary bladder cancer	3.32e-06	3.22e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—NQO1—urinary bladder cancer	3.28e-06	3.18e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—SRC—urinary bladder cancer	3.23e-06	3.13e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—CREBBP—urinary bladder cancer	3.2e-06	3.11e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—GPX1—urinary bladder cancer	3.19e-06	3.09e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	3.19e-06	3.09e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	3.17e-06	3.07e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—EP300—urinary bladder cancer	3.17e-06	3.07e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—GSTP1—urinary bladder cancer	3.14e-06	3.05e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—NAT2—urinary bladder cancer	3.14e-06	3.04e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—ERCC2—urinary bladder cancer	3.14e-06	3.04e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—GSTP1—urinary bladder cancer	3.13e-06	3.03e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—PTGS2—urinary bladder cancer	3.09e-06	3e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—PTGS2—urinary bladder cancer	3.09e-06	3e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	3.04e-06	2.95e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	3.02e-06	2.93e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—MTHFR—urinary bladder cancer	2.95e-06	2.86e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—TYMS—urinary bladder cancer	2.92e-06	2.83e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—TYMS—urinary bladder cancer	2.91e-06	2.82e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—GSTM1—urinary bladder cancer	2.89e-06	2.8e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—NCOR1—urinary bladder cancer	2.89e-06	2.8e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—GSTM1—urinary bladder cancer	2.87e-06	2.78e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—NCOR1—urinary bladder cancer	2.87e-06	2.78e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—PTGS2—urinary bladder cancer	2.83e-06	2.75e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—GPX1—urinary bladder cancer	2.77e-06	2.68e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—GPX1—urinary bladder cancer	2.75e-06	2.67e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—GSTP1—urinary bladder cancer	2.74e-06	2.65e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—ERCC2—urinary bladder cancer	2.72e-06	2.63e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—RRM2—urinary bladder cancer	2.71e-06	2.63e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—ERCC2—urinary bladder cancer	2.7e-06	2.62e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—PTEN—urinary bladder cancer	2.7e-06	2.61e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—PTEN—urinary bladder cancer	2.7e-06	2.61e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—KRAS—urinary bladder cancer	2.67e-06	2.59e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—PTGS2—urinary bladder cancer	2.62e-06	2.54e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—EP300—urinary bladder cancer	2.57e-06	2.49e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—EP300—urinary bladder cancer	2.57e-06	2.49e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—MTHFR—urinary bladder cancer	2.55e-06	2.47e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—TYMS—urinary bladder cancer	2.55e-06	2.47e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—MTHFR—urinary bladder cancer	2.54e-06	2.46e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—GSTM1—urinary bladder cancer	2.52e-06	2.44e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—NCOR1—urinary bladder cancer	2.52e-06	2.44e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	2.51e-06	2.43e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—ENO2—urinary bladder cancer	2.51e-06	2.43e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—PTEN—urinary bladder cancer	2.47e-06	2.4e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	2.43e-06	2.36e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—GPX1—urinary bladder cancer	2.41e-06	2.34e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—PPARG—urinary bladder cancer	2.39e-06	2.32e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—TP53—urinary bladder cancer	2.38e-06	2.3e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—ERCC2—urinary bladder cancer	2.37e-06	2.29e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—EP300—urinary bladder cancer	2.36e-06	2.28e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—CREBBP—urinary bladder cancer	2.3e-06	2.22e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—PTEN—urinary bladder cancer	2.29e-06	2.22e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—HRAS—urinary bladder cancer	2.27e-06	2.2e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—MTHFR—urinary bladder cancer	2.22e-06	2.16e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—EP300—urinary bladder cancer	2.18e-06	2.11e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—PPARG—urinary bladder cancer	2.07e-06	2.01e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—PPARG—urinary bladder cancer	2.06e-06	1.99e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—NQO1—urinary bladder cancer	2.02e-06	1.96e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—CREBBP—urinary bladder cancer	1.99e-06	1.93e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—CREBBP—urinary bladder cancer	1.98e-06	1.92e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—PTGS2—urinary bladder cancer	1.88e-06	1.82e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—PPARG—urinary bladder cancer	1.8e-06	1.75e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—CREBBP—urinary bladder cancer	1.73e-06	1.68e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	1.69e-06	1.63e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—PTEN—urinary bladder cancer	1.64e-06	1.59e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—PTGS2—urinary bladder cancer	1.63e-06	1.58e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—PTGS2—urinary bladder cancer	1.62e-06	1.57e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—TYMS—urinary bladder cancer	1.57e-06	1.52e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—EP300—urinary bladder cancer	1.56e-06	1.52e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	1.55e-06	1.5e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	1.55e-06	1.5e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—GPX1—urinary bladder cancer	1.48e-06	1.44e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	1.46e-06	1.41e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—PTEN—urinary bladder cancer	1.42e-06	1.38e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—PTGS2—urinary bladder cancer	1.42e-06	1.37e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—PTEN—urinary bladder cancer	1.41e-06	1.37e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	1.37e-06	1.33e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—EP300—urinary bladder cancer	1.35e-06	1.31e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—EP300—urinary bladder cancer	1.35e-06	1.3e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—PTEN—urinary bladder cancer	1.24e-06	1.2e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—EP300—urinary bladder cancer	1.18e-06	1.14e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—PPARG—urinary bladder cancer	1.11e-06	1.08e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	1.07e-06	1.03e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	8.74e-07	8.47e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—PTEN—urinary bladder cancer	7.62e-07	7.39e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—EP300—urinary bladder cancer	7.27e-07	7.04e-06	CbGpPWpGaD
